Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL)

Clinical trial NCT02367040 · COMPLETED

Trial details

NCT number: NCT02367040
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Lymphoma,Non-Hodgkin

Start date: 2015-08-03
Primary completion: 2020-08-31
Enrollment: 458

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.